Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07106879 · ClinicalTrials.gov registry record
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
A clinical trial of Obesity and Cardiovascular Diseases, sponsored by Clindove Research.
- Recruiting
- Registry status
- 7,000
- Enrollment target
- 1
- Study location
NCT07106879 is a study of Obesity and Cardiovascular Diseases that is actively recruiting participants, run by Clindove Research. The registered enrollment target is 7,000 participants, above the 812-participant average among 1,053 other Obesity trials with a reported enrollment target (762% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07106879, a study of Obesity and Cardiovascular Diseases, is actively recruiting participants, sponsored by Clindove Research.
- RECRUITING
- Registry status
- 7,000 participants
- Enrollment target
- 1
- Study location
Study Summary
DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current health conditions and symptoms. The study team may also collect basic health information, including vital signs, urine drug tests, blood samples and pregnancy tests (if applicable). A physician will review each participant's medical history in a one-on-one interview to assess potential fit for upcoming trials. If needed, the doctor may contact the participant's current doctors or pharmacies to gather more information for eligibility review.
Conditions Studied
Interventions
- OTHER Blood Work
Study Locations (1)
New York
- Clindove Research LLC - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,000 participants |
| Start Date | 2025-07-30 |
| Est. Completion | 2030-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07106879
The ClinicalTrials.gov registry entry for NCT07106879 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 7,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 812-participant average among 1,053 other Obesity trials with a reported enrollment target (762% higher). The listed sponsor is Clindove Research, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Blood Work is the first listed.
NCT07106879 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07106879 about?
NCT07106879 is a clinical study titled "Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.". DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current healt...
What is the current status of trial NCT07106879?
This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 2025-07-30. Estimated completion is 2030-12-01.
What conditions does trial NCT07106879 study?
This clinical trial studies the following conditions: Obesity, Cardiovascular Diseases, Metabolic Syndrome, PreDiabetes, Type 2 Diabetes Mellitus (T2DM).
What interventions are being tested in trial NCT07106879?
The interventions under investigation include: Blood Work (OTHER).
Who is sponsoring clinical trial NCT07106879?
This trial is sponsored by Clindove Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07106879 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.